HomeEXECUTIVESClosed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer

Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer

Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that enable personalized dose optimization, today announced that it has appointed Konstantinos Vlassis as Chief Technology Officer (CTO). Bringing extensive expertise in designing and implementing technology strategies to support product delivery, Konstantinos will oversee the management of the Company’s technology platforms and will have responsibility for engineering, information security and technology infrastructure.

Konstantinos is an experienced technology leader with more than 20 years of experience in building high performance agile teams. As CTO, he will play a pivotal role in leading Closed Loop Medicine’s Engineering Team and facilitating cross-functional collaboration. Konstantinos will be a key member of the Executive Leadership Team working to meet short- and long-term business goals and growth.

During his career, Konstantinos created scalable high-transaction platforms, re-architected legacy applications to Service Oriented Architecture and refactored solutions from different programming languages to deliver B2B and B2C products in healthcare, market research and data companies.

In his previous role, Konstantinos was CTO at Medis Medical Imaging, where he established a full agile continuous integration and delivery process, while initiating a major digital transformation of the company’s products incorporating AI/ML tools. During that time, Konstantinos secured the acquisition of AMID, an Italian software-as-a-medical-device company, and launched the first Medis product incorporating the acquired technology. Prior to this, Konstantinos was the interim CTO at Winnow Systems Ltd, during which time he led the development and successful release of the award-winning AI product Winnow Vision which has been widely used in the hospitality industry to reduce food-waste. Konstantinos holds an MBA from Cass Business School, and MSc Information Systems from Brunel University.

Konstantinos Vlassis, CTO of Closed Loop Medicine, commented: “I am thrilled to be joining Closed Loop Medicine and becoming an integral part of the development of our technology platform and overall software engineering, information security, and infrastructure to support bringing these life-changing products to the market. I am excited to work closely with the product, regulatory and operational teams to leverage the capabilities of our ground-breaking technologies that have the potential to revolutionize disease management and improve health outcomes for millions of patients.”

Dr. Hakim Yadi PhD OBE, CEO & Co-Founder of Closed Loop Medicine, said: “It has been a pivotal year for the Company’s growth, particularly to establish strategic collaborations and strengthen our senior leadership team. As Chief Technology Officer, Konstantinos brings a wealth of experience in designing and implementing productive, transparent, accountable technology strategies within strict regulatory constraints and delivering innovative products. As we continue to develop our dose optimization combination products enabling bespoke treatment decisions at an individual patient level, the expertise Konstantinos brings to the team is invaluable and I’m delighted to welcome him to the team.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.
Broken String Biosciences reports Gavin Burns will be responsible for building and optimizing the companys teams, processes, and systems.
“We are pleased to strengthen our Clinical Advisory Board and to welcome our new members,” commented Pierre Leurent, President, Aptar Digital Health. “Their broad medical expertise will allow us to have a deeper knowledge and expand our global vision of the clinical practice for multiple types of cancer.”
Dr Ronald Silverman will be responsible for leading the company's Medical Affairs organization, which includes end-to-end medical affairs across BD's business units, regions and central team. In this role, he will use medical insights and expertise to advance BD's pipeline of clinically relevant, innovative solutions that align with evolving patient needs, while also contributing to the safety and compliance of BD's in-market portfolio of products.

By using this website you agree to accept Medical Device News Magazine Privacy Policy